Market Cap 26.47M
Revenue (ttm) 15.65M
Net Income (ttm) -370,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2.36%
Debt to Equity Ratio 0.00
Volume 30,100
Avg Vol 52,246
Day's Range N/A - N/A
Shares Out 5.39M
Stochastic %K 70%
Beta 0.48
Analysts Sell
Price Target $9.77

Company Profile

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7 for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 439 5551
Address:
100 Summit Drive, Burlington, United States
I_am_retail_investor
I_am_retail_investor Apr. 24 at 4:04 PM
$NEUP - man, a press release now touting BNC-210 for PTSD would really capitalize on the recent White House EO, look at $ENVB one-month chart
0 · Reply
frontiere
frontiere Apr. 22 at 2:16 PM
$NEUP Neuphoria ex $BNOX Bionomics — Long — anyone here picked up on CEO Spyros resigning from his $LPCN Lipocine Chairmanship with a disagreement? Breadcrumbs, but I see it as a small good sign — I was a bit wary of how actively he is involved in NEUP right now. Also LPCN is an interesting cigar butt long if goes <$2.00 again ;)
1 · Reply
VolcanicTrades
VolcanicTrades Apr. 20 at 7:55 PM
$NEUP setting up ⬆️
0 · Reply
KingZack25
KingZack25 Apr. 20 at 7:25 PM
$NEUP new high for the year!
0 · Reply
I_am_retail_investor
I_am_retail_investor Apr. 20 at 5:50 PM
$NEUP - hoping $NEUP hypes their BNC-201 with their current strategic/business development, current White House focus on PTSD is timely for their oral, proprietary, selective negative allosteric modulator of the α7 nicotinic acetylcholine receptor.
1 · Reply
I_am_retail_investor
I_am_retail_investor Apr. 16 at 11:30 PM
$NEUP - Executive Order expected soon to increase research into ibogaine’s effectiveness for PTSD, should have some spillover value-bump effect for $NEUP’s BNC-210 for PTSD.
0 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 16 at 3:30 PM
$VTGN Any good CEO already has a contingency plan in place in case data is not good. Most likely they are already in talks for some sort of strategic alt deal if the data is meh. $RLYB did it, $CYCN did it, $BRNS did it, $NEUP did it, all behind the scenes while waiting on data and continuing business as usual. With 60m cash on hand Dec 31, and likely 45m+ on hand today we are trading at over 1/2 cash value. Any binary announcement likely has limited downside and loads of upside. Again, no matter the result here I still think it is a asymmetrical risk/reward situation. Risk -30% to possibly gain 100%+ Do your own DD of course but I've loaded up the boat. Options: A). Data is good, stock pumps B). Data is bad, announce strat alt review , stock rebounds to near current levels C). Reverse merger deal out of nowhere, stock explodes based on cash position. Look at $RLYB $CYCN $BRNS etc. All of them happened out of nowhere.
2 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 13 at 6:42 PM
$NEUP RSI: 48.19, MACD: 0.0631 Vol: 0.24, MA20: 4.44, MA50: 4.34 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Quido22
Quido22 Apr. 8 at 7:01 AM
$NEUP How could this be a reverse merger when, in my view, the company has valuable assets such as the Merck collaboration, the Carina partnership, and other patents? I wouldn’t say anything if the company had nothing to offer, but in this case, an RM doesn’t make sense for shareholders. The only people who would benefit would be those personally filling their own pockets.
2 · Reply
Quido22
Quido22 Apr. 8 at 6:58 AM
$NEUP In my view, a reverse merger would be the worst-case scenario for shareholders, even worse than a buyout by Lynx1. The CEO has not been communicating with me—would it be possible for someone to find out more information about this?
1 · Reply
Latest News on NEUP
Neuphoria Therapeutics Inc. Sends Letter to Stockholders

Nov 24, 2025, 8:00 AM EST - 5 months ago

Neuphoria Therapeutics Inc. Sends Letter to Stockholders


Neuphoria Provides First Quarter 2025 Business Updates

May 20, 2025, 4:22 PM EDT - 1 year ago

Neuphoria Provides First Quarter 2025 Business Updates


Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans


I_am_retail_investor
I_am_retail_investor Apr. 24 at 4:04 PM
$NEUP - man, a press release now touting BNC-210 for PTSD would really capitalize on the recent White House EO, look at $ENVB one-month chart
0 · Reply
frontiere
frontiere Apr. 22 at 2:16 PM
$NEUP Neuphoria ex $BNOX Bionomics — Long — anyone here picked up on CEO Spyros resigning from his $LPCN Lipocine Chairmanship with a disagreement? Breadcrumbs, but I see it as a small good sign — I was a bit wary of how actively he is involved in NEUP right now. Also LPCN is an interesting cigar butt long if goes <$2.00 again ;)
1 · Reply
VolcanicTrades
VolcanicTrades Apr. 20 at 7:55 PM
$NEUP setting up ⬆️
0 · Reply
KingZack25
KingZack25 Apr. 20 at 7:25 PM
$NEUP new high for the year!
0 · Reply
I_am_retail_investor
I_am_retail_investor Apr. 20 at 5:50 PM
$NEUP - hoping $NEUP hypes their BNC-201 with their current strategic/business development, current White House focus on PTSD is timely for their oral, proprietary, selective negative allosteric modulator of the α7 nicotinic acetylcholine receptor.
1 · Reply
I_am_retail_investor
I_am_retail_investor Apr. 16 at 11:30 PM
$NEUP - Executive Order expected soon to increase research into ibogaine’s effectiveness for PTSD, should have some spillover value-bump effect for $NEUP’s BNC-210 for PTSD.
0 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 16 at 3:30 PM
$VTGN Any good CEO already has a contingency plan in place in case data is not good. Most likely they are already in talks for some sort of strategic alt deal if the data is meh. $RLYB did it, $CYCN did it, $BRNS did it, $NEUP did it, all behind the scenes while waiting on data and continuing business as usual. With 60m cash on hand Dec 31, and likely 45m+ on hand today we are trading at over 1/2 cash value. Any binary announcement likely has limited downside and loads of upside. Again, no matter the result here I still think it is a asymmetrical risk/reward situation. Risk -30% to possibly gain 100%+ Do your own DD of course but I've loaded up the boat. Options: A). Data is good, stock pumps B). Data is bad, announce strat alt review , stock rebounds to near current levels C). Reverse merger deal out of nowhere, stock explodes based on cash position. Look at $RLYB $CYCN $BRNS etc. All of them happened out of nowhere.
2 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 13 at 6:42 PM
$NEUP RSI: 48.19, MACD: 0.0631 Vol: 0.24, MA20: 4.44, MA50: 4.34 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Quido22
Quido22 Apr. 8 at 7:01 AM
$NEUP How could this be a reverse merger when, in my view, the company has valuable assets such as the Merck collaboration, the Carina partnership, and other patents? I wouldn’t say anything if the company had nothing to offer, but in this case, an RM doesn’t make sense for shareholders. The only people who would benefit would be those personally filling their own pockets.
2 · Reply
Quido22
Quido22 Apr. 8 at 6:58 AM
$NEUP In my view, a reverse merger would be the worst-case scenario for shareholders, even worse than a buyout by Lynx1. The CEO has not been communicating with me—would it be possible for someone to find out more information about this?
1 · Reply
I_am_retail_investor
I_am_retail_investor Apr. 8 at 12:52 AM
$NEUP - with all the insanity and mental trauma that Trump et al. are creating, any drug interventions that can provide relief (without brain fog) should be getting more attention based purely on patient demand .. I can’t imagine drug companies not thinking about this ..
0 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 7 at 6:27 PM
$NEUP What the CEO's response below tells me is that this is almost definitely a RM since they are 'refining the list of companies'. Then the question becomes why is it taking so long? $SNSE was able to pull of a quick RM. Valuing the company if they have no assets is relatively easy, so I believe the hold up here may be the assets that NEUP holds (BNC210 and the Merck partnered asset). The 'complication' or 'hold-up' may be figuring out the value and/or negotiating sales of these assets before the RM is finalized. The timing may be taking longer than we had hoped, but I'm more bullish than ever on a very positive outcome here because of this so called 'lengthy process'.
2 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 7 at 6:19 PM
$NEUP Both the $GLTO and $BRNS CEO's sent me similiar responses and then the deal was announced with 10 days of each of them...so assuming timing is always iffy. But this is a good, solid response. Thanks for sharing.
0 · Reply
hbkstockislife
hbkstockislife Apr. 7 at 6:15 PM
$NEUP it says below ..will take some few more months
0 · Reply
hbkstockislife
hbkstockislife Apr. 7 at 6:14 PM
$NEUP Dear RD, The process is progressing nicely, and we are continuing to refine the list of companies. Thank you for your continued support. Best regards, Spyros Spyros Papapetropoulos MD, PhD Interim CEO Neuphoria Therapeutics Inc
1 · Reply
I_am_retail_investor
I_am_retail_investor Apr. 1 at 7:23 PM
$NEUP - sustainable UP for NEUP or temporary blip-up (?)
0 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 1 at 6:05 PM
$NEUP I've upped my stake here to now a 1.8% owner of NEUP after the $CYCN win today. Still believe in the likely outcomes below. Timing is the big question but we are now officially 5 months into strat alts so I expect a resolution by the end of April given typical 4-6 month timeframes on these things. Worth the wait!
1 · Reply
isu2b3vrysus
isu2b3vrysus Apr. 1 at 4:20 PM
$NEUP Holding until deal. Feels almost too good to be true, but after RLYB i’ve realized that these types of plays don’t carry much risk - I suppose that after two months if nothing happens, I sell with no loss. Yes there is opportunity cost, but the risk/reward is much higher overall than pretty much any other play. Would love to hear thoughts on timeline though.
1 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 1 at 1:59 PM
$NEUP Bought more shares today w/ my $CYCN winnings :)
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Apr. 1 at 11:48 AM
$NEUP $CYCN epic R/M today. We're next..
0 · Reply
skyrockets_Inc
skyrockets_Inc Mar. 31 at 6:57 PM
$NEUP $KZR got deal two days ago, today is $APLS, next is $NEUP !
1 · Reply
BuyNow_SellLater
BuyNow_SellLater Mar. 27 at 4:52 PM
$NEUP good day to add here
0 · Reply